Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2026 | 1 | -$0.09 | -$0.08 | -$0.09 |
| Q3 2026 | 1 | -$0.10 | -$0.09 | -$0.09 |
| Q4 2026 | 1 | -$0.05 | -$0.04 | -$0.05 |
| Q1 2027 | 1 | -$0.09 | -$0.08 | -$0.09 |
| Q2 2027 | 1 | -$0.08 | -$0.07 | -$0.08 |
| Q3 2027 | 1 | -$0.08 | -$0.07 | -$0.08 |
| Q4 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2028 | 1 | -$0.05 | -$0.04 | -$0.05 |
| Q2 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2028 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2028 | 1 | $0.01 | $0.01 | $0.01 |
Apyx Medical Corp last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.06. The company had revenue of 12.49 M for the quarter and had revenue of 52.84 M for the year. Apyx Medical Corp has generated $0 earnings per share over the last year ($-0.27 diluted earnings per share) and currently has a price-to-earnings ratio of -18.81. Apyx Medical Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.11 | -$0.05 | 0.06 | $10.53 M | $12.49 M |
| 03/10/2026 | Q4 2025 | -$0.06 | -$0.03 | 0.03 | $18.54 M | $19.16 M |
| 11/06/2025 | Q3 2025 | -$0.06 | -$0.05 | 0.01 | $12.00 M | $12.88 M |
| 08/07/2025 | Q2 2025 | -$0.09 | -$0.09 | 0 | $11.70 M | $11.37 M |
| 05/08/2025 | Q1 2025 | -$0.12 | -$0.12 | 0 | $9.39 M | $9.43 M |
| 03/13/2025 | Q4 2024 | -$0.13 | -$0.12 | 0.01 | $13.39 M | $14.22 M |
| 11/08/2024 | Q3 2024 | -$0.15 | -$0.14 | 0.01 | $11.38 M | $11.49 M |
| 08/08/2024 | Q2 2024 | -$0.18 | -$0.19 | -0.01 | $11.75 M | $12.15 M |
| 05/09/2024 | Q1 2024 | -$0.18 | -$0.22 | -0.04 | $9.53 M | $10.24 M |
| 03/21/2024 | Q4 2023 | -$0.13 | -$0.28 | -0.15 | N/A | $14.66 M |
| 11/09/2023 | Q3 2023 | -$0.10 | -$0.13 | -0.03 | N/A | $11.98 M |
| 08/10/2023 | Q2 2023 | N/A | -$0.03 | N/A | N/A | $13.57 M |
| 05/11/2023 | Q1 2023 | -$0.06 | -$0.10 | -0.04 | N/A | $12.14 M |
| 03/16/2023 | Q4 2022 | $0.14 | -$0.17 | -0.31 | N/A | $12.61 M |
| 11/10/2022 | Q3 2022 | -$0.12 | -$0.17 | -0.05 | N/A | $9.11 M |
| 08/11/2022 | Q2 2022 | -$0.20 | -$0.16 | 0.04 | N/A | $10.29 M |
| 05/12/2022 | Q1 2022 | -$0.13 | -$0.17 | -0.04 | N/A | $12.49 M |
| 03/17/2022 | Q4 2021 | -$0.13 | -$0.06 | 0.07 | N/A | $16.82 M |
| 11/12/2021 | Q3 2021 | N/A | -$0.12 | N/A | N/A | $11.83 M |
| 08/12/2021 | Q2 2021 | -$0.14 | -$0.12 | 0.02 | N/A | $11.22 M |
In the previous quarter, Apyx Medical Corp (:APYX) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.06.
The conference call for Apyx Medical Corp's latest earnings report can be listened to online.
The conference call transcript for Apyx Medical Corp's latest earnings report can be read online.
Apyx Medical Corp (:APYX) has a recorded annual revenue of $52.84 M.
Apyx Medical Corp (:APYX) has a recorded net income of $-11,211,000.Apyx Medical Corp has generated $-0.27 earnings per share over the last four quarters.
Apyx Medical Corp (:APYX) has a price-to-earnings ratio of -18.81 and price/earnings-to-growth ratio is -0.16.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED